RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Vectura Group Stock

Vectura Group P/S 2024

Vectura Group P/S

4.73

Ticker

VEC.L

ISIN

GB00BKM2MW97

WKN

A2PTCY

As of Jul 13, 2024, Vectura Group's P/S ratio stood at 4.73, a 0% change from the 0 P/S ratio recorded in the previous year.

The Vectura Group P/S history

Vectura Group Aktienanalyse

What does Vectura Group do?

The Vectura Group PLC is a British company specializing in the development of inhalable medications. The company was founded in 1997 and is headquartered in Chippenham, England. History: Initially, Vectura focused on the development of products for the treatment of asthma and chronic obstructive pulmonary disease (COPD). In 2014, the company acquired competitor Skyepharma, expanding its product range to include a wider spectrum of inhalable medications and active ingredients. Business Model: Vectura's business model is based on collaborating with its partners to develop inhalable therapies and active ingredients. The company itself acts as a service provider, offering support to the pharmaceutical industry in the development of new solutions. Vectura has a wide range of technologies and expertise to offer its customers tailored solutions. Divisions: Vectura is divided into four different business units. "Inhaled Therapies" offers solutions for inhaling medications, including inhalers equipped with special propellants to deliver the active ingredients directly to the lungs. The "Royalty-Driven Products" division includes products for which Vectura holds licenses and benefits from the sales of these products. In the "Device Services" division, the company offers development and design services for inhalable therapies. Finally, Vectura also has a research department referred to as "New Product Opportunities," where the company works on the development of new technologies and therapies. Products: Vectura's key products include treatments for asthma and COPD, such as the inhaler Flutiform and the medication Seebri. The company also offers inhalable therapies for other diseases, such as cystic fibrosis and pulmonary hypertension. In addition to medical applications, Vectura also develops more sustainable inhalers and devices that do not rely on chlorofluorocarbons (CFCs) or other environmentally harmful propellants. Conclusion: Vectura has established itself as one of the leading companies in the field of inhalable medications. The company offers tailored solutions for its customers and invests in the development of new technologies to enhance inhalation therapy. Vectura has expanded its portfolio in recent years through the acquisition of Skyepharma and aims to further expand its market position. Vectura Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Vectura Group's P/S Ratio

Vectura Group's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Vectura Group's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Vectura Group's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Vectura Group’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Vectura Group stock

What is the price-to-earnings ratio of Vectura Group?

The price-earnings ratio of Vectura Group is currently 4.73.

How has the price-earnings ratio of Vectura Group changed compared to last year?

The price-to-earnings ratio of Vectura Group has increased by 0% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Vectura Group high compared to other companies?

Yes, the price-to-earnings ratio of Vectura Group is high compared to other companies.

How does an increase in the price-earnings ratio of Vectura Group affect the company?

An increase in the price-earnings ratio of Vectura Group would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Vectura Group affect the company?

A decrease in the price-earnings ratio of Vectura Group would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Vectura Group?

Some factors that influence the price-earnings ratio of Vectura Group are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Vectura Group pay?

Over the past 12 months, Vectura Group paid a dividend of 0.06 GBP . This corresponds to a dividend yield of about 3.64 %. For the coming 12 months, Vectura Group is expected to pay a dividend of 0 GBP.

What is the dividend yield of Vectura Group?

The current dividend yield of Vectura Group is 3.64 %.

When does Vectura Group pay dividends?

Vectura Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Vectura Group?

Vectura Group paid dividends every year for the past 0 years.

What is the dividend of Vectura Group?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Vectura Group located?

Vectura Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Vectura Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vectura Group from 6/11/2021 amounting to 0.19 GBP, you needed to have the stock in your portfolio before the ex-date on 6/1/2021.

When did Vectura Group pay the last dividend?

The last dividend was paid out on 6/11/2021.

What was the dividend of Vectura Group in the year 2023?

In the year 2023, Vectura Group distributed 0 GBP as dividends.

In which currency does Vectura Group pay out the dividend?

The dividends of Vectura Group are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Vectura Group stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Vectura Group

Our stock analysis for Vectura Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vectura Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.